Education
About Us
Working with TipRanks
Follow Us
Estrella Immunopharma (ESLA)
NASDAQ:ESLA
RESEARCH TOOLSreports
| Jun 24 | Dec 22 | Jun 22 | Jun 21 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -7.31M | $ -1.57M | $ -1.69M | $ -733.69K |
| EBITDA | $ -7.31M | $ -915.46K | $ -247.72K | $ -733.69K |
| Net Income | $ -7.31M | $ -996.10K | $ -1.69M | $ -733.69K |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ 4.17M | $ 40.80K | $ 4.09M | $ 0.00 |
| Total Assets | $ 4.45M | $ 9.99M | $ 4.92M | $ 0.00 |
| Total Debt | $ 0.00 | $ 498.60K | $ 0.00 | $ 0.00 |
| Net Debt | $ -4.17M | $ 457.80K | $ -4.09M | $ 0.00 |
| Total Liabilities | $ 180.70K | $ 2.92M | $ 5.96M | $ 0.00 |
| Stockholders' Equity | $ 4.27M | $ 7.07M | $ -1.04M | $ 0.00 |
| Cash Flow | ||||
| Free Cash Flow | $ -16.07M | $ -1.04M | $ -1.44M | $ -670.82K |
| Operating Cash Flow | $ -16.07M | $ -1.04M | $ -1.44M | $ -670.82K |
| Investing Cash Flow | $ 4.96M | $ 36.17M | $ -45.19M | $ 0.00 |
| Financing Cash Flow | $ 12.79M | $ -35.56M | $ 5.53M | $ 670.82K |
Estrella Immunopharma Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.